{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Xenon Pharmaceuticals Inc."},"Symbol":{"label":"Symbol","value":"XENE"},"Address":{"label":"Address","value":"200-3650 GILMORE WAY, BURNABY, British Columbia, V5G 4W8, Canada"},"Phone":{"label":"Phone","value":"+1 604 484-3300"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets."},"CompanyUrl":{"label":"Company Url","value":"https://www.xenon-pharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher Kenney","title":"Chief Medical Officer"},{"name":"Ian C. Mortimer","title":"President, Chief Executive Officer & Director"},{"name":"Matthew D. Ronsheim","title":"Chief Operating Officer"},{"name":"Sheila M. Grant","title":"Executive VP-Research & Development Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}